Speaker illustration

Doctor Tomoko Ichiki

Mayo Clinic, Division of Cardiovascular Diseases and Internal Medicine, Rochester (United States of America)

Cardiorenal protection by subcutaneous cenderitide in experimental heart failure: a novel and safe therapeutic for humans with LVAD support

Event: ESC Congress 2018

Topic: Pharmacotherapy

Session: Chronic heart failure – Treatment

Thumbnail

Circulating corin in the general community: link to gender and metabolic dysfunction

Event: ESC Congress 2018

Topic: Biomarkers

Session: Risk factors and prevention

Thumbnail

Superior actions of chronic peptide therapeutics with Cenderitide on cardiorenal function and remodeling compared to enalapril through reverse activation of gene pathways in experimental heart failure

Event: ESC CONGRESS 2016

Topic: Pharmacologic therapy

Session: Drug therapy of heart failure

Thumbnail

This platform is supported by

logo Novo Nordisk